HUMATROPE is indicated for the long-term treatment of children who have growth failure due to inadequate secretion of normal endogenous growth hormone.,HUMATROPE is also indicated for the treatment of growth disturbances associated with gonadal dysgenesis (Turner syndrome).,HUMATROPE is also indicated for the treatment of adults with severe growth hormone deficiency defined as patients with known hypothalamic-pituitary pathology and at least one known deficiency of a pituitary hormone not being prolactin. These patients should undergo a single dynamic test in order to diagnose or exclude a growth deficiency.
In patients with childhood onset isolated GH deficiency (no evidence of hypothalamic-pituitary disease or cranal irradiation), two dynamic tests should be recommended, except for those having low IGF-I concentrations less than or equal to 2 SDS who may be considered for one test. The cut-off point of the dynamic test should be strict.,HUMATROPE is also indicated for the treatment of growth retardation in prepubertal children with chronic renal insufficiency whose height is on or less than the twenty-fifth percentile and whose growth velocity is on or less than the twenty-fifth percentile for bone age. Chronic renal insufficiency is defined as glomerular filtration rate of less than 30 mL/min/1.73 m2.,HUMATROPE is also indicated for the treatment of growth failure in children born small for gestational age (SGA) who fail to demonstrate catch-up growth by age two to four years (see CLINICAL TRIALS).,Humatrope is also indicated for the treatment of growth failure in children born small for gestational age (SGA) who fail to demonstrate catch-up growth by age two to four years. (See Clinical Trials)
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, powder for
White or almost white powder.
The way to take this medicine is: Intramuscular.
This medicine is given through a needle inserted into the muscle beneath the skin.
Part 2: Injection, solution
Clear liquid.
The way to take this medicine is: Intramuscular.
This medicine is given through a needle inserted into the muscle beneath the skin.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
Store at 2 to 8 degrees Celsius
Do not Freeze
Refrigerate
Shelf lifetime is 3 Years.
Do I need a prescription?
These medicine packs are available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
1 cartridge of powder - 18IU (6mg) pack
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is
Not Scheduled.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
HUMATROPE is indicated for the long-term treatment of children who have growth failure due to inadequate secretion of normal endogenous growth hormone.,HUMATROPE is also indicated for the treatment of growth disturbances associated with gonadal dysgenesis (Turner syndrome).,HUMATROPE is also indicated for the treatment of adults with severe growth hormone deficiency defined as patients with known hypothalamic-pituitary pathology and at least one known deficiency of a pituitary hormone not being prolactin. These patients should undergo a single dynamic test in order to diagnose or exclude a growth deficiency.
In patients with childhood onset isolated GH deficiency (no evidence of hypothalamic-pituitary disease or cranal irradiation), two dynamic tests should be recommended, except for those having low IGF-I concentrations less than or equal to 2 SDS who may be considered for one test. The cut-off point of the dynamic test should be strict.,HUMATROPE is also indicated for the treatment of growth retardation in prepubertal children with chronic renal insufficiency whose height is on or less than the twenty-fifth percentile and whose growth velocity is on or less than the twenty-fifth percentile for bone age. Chronic renal insufficiency is defined as glomerular filtration rate of less than 30 mL/min/1.73 m2.,HUMATROPE is also indicated for the treatment of growth failure in children born small for gestational age (SGA) who fail to demonstrate catch-up growth by age two to four years (see CLINICAL TRIALS).,Humatrope is also indicated for the treatment of growth failure in children born small for gestational age (SGA) who fail to demonstrate catch-up growth by age two to four years. (See Clinical Trials)
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, solution
Clear liquid.
The way to take this medicine is: Intramuscular.
This medicine is given through a needle inserted into the muscle beneath the skin.
Part 2: Injection, powder for
White or almost white powder.
The way to take this medicine is: Intramuscular.
This medicine is given through a needle inserted into the muscle beneath the skin.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
Store at 2 to 8 degrees Celsius
Refrigerate
Do not Freeze
Shelf lifetime is 3 Years.
Do I need a prescription?
These medicine packs are available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
1 cartridge of powder - 72IU (24mg) pack
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is
Not Scheduled.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
HUMATROPE is indicated for the long-term treatment of children who have growth failure due to inadequate secretion of normal endogenous growth hormone.,HUMATROPE is also indicated for the treatment of growth disturbances associated with gonadal dysgenesis (Turner syndrome).,HUMATROPE is also indicated for the treatment of adults with severe growth hormone deficiency defined as patients with known hypothalamic-pituitary pathology and at least one known deficiency of a pituitary hormone not being prolactin. These patients should undergo a single dynamic test in order to diagnose or exclude a growth deficiency.
In patients with childhood onset isolated GH deficiency (no evidence of hypothalamic-pituitary disease or cranal irradiation), two dynamic tests should be recommended, except for those having low IGF-I concentrations less than or equal to 2 SDS who may be considered for one test. The cut-off point of the dynamic test should be strict.,HUMATROPE is also indicated for the treatment of growth retardation in prepubertal children with chronic renal insufficiency whose height is on or less than the twenty-fifth percentile and whose growth velocity is on or less than the twenty-fifth percentile for bone age. Chronic renal insufficiency is defined as glomerular filtration rate of less than 30 mL/min/1.73 m2.,HUMATROPE is also indicated for the treatment of growth failure in children born small for gestational age (SGA) who fail to demonstrate catch-up growth by age two to four years (see CLINICAL TRIALS).,Humatrope is also indicated for the treatment of growth failure in children born small for gestational age (SGA) who fail to demonstrate catch-up growth by age two to four years. (See Clinical Trials)
How to take it
This medicine is a pack that contains more than one part.
Part 1: Injection, solution
Clear liquid.
The way to take this medicine is: Intramuscular.
This medicine is given through a needle inserted into the muscle beneath the skin.
Part 2: Injection, powder for
White or almost white powder
The way to take this medicine is: Intramuscular.
This medicine is given through a needle inserted into the muscle beneath the skin.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
Store at 2 to 8 degrees Celsius
Refrigerate
Do not Freeze
Shelf lifetime is 3 Years.
Do I need a prescription?
These medicine packs are available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
1 cartridge of powder - 36IU (12.0mg) pack
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is
Not Scheduled.
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
